发明名称 |
CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1 H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1 -YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST |
摘要 |
The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist. |
申请公布号 |
SG11201604541W(A) |
申请公布日期 |
2016.07.28 |
申请号 |
SG11201604541W |
申请日期 |
2014.12.02 |
申请人 |
ACTELION PHARMACEUTICALS LTD |
发明人 |
BOSS, CHRISTOPH;BROTSCHI, CHRISTINE;GUDE, MARKUS;HEIDMANN, BIBIA;SIFFERLEN, THIERRY;VON RAUMER, MARKUS;WILLIAMS, JODI T. |
分类号 |
C07D403/14;A61K31/4192;A61P25/00 |
主分类号 |
C07D403/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|